141 related articles for article (PubMed ID: 30776300)
1. Paradoxical Arthritis in Inflammatory Bowel Diasease Patients on Ustekinumab Treatment.
García García MJ; Rivero Tirado M; Callizo MEP
Inflamm Bowel Dis; 2019 Jun; 25(7):e89. PubMed ID: 30776300
[No Abstract] [Full Text] [Related]
2. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
3. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
[No Abstract] [Full Text] [Related]
4. How effective is ustekinumab in controlling psoriatic arthritis?
Bonifati C; Graceffa D
Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
[TBL] [Abstract][Full Text] [Related]
5. Stroke under treatment with ustekinumab for psoriatic arthritis.
Aboudiab M; Andréjak M; Husein T; Goëb V
Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
[No Abstract] [Full Text] [Related]
6. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
7. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
8. Flare of palmoplantar psoriasis with ustekinumab.
Daniel BS; Baker C; Foley P
Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
[No Abstract] [Full Text] [Related]
9. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
Nakayama C; Fujita Y; Watanabe M; Shimizu H
J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab associated with flares of psoriatic arthritis.
Stamell EF; Kutner A; Viola K; Cohen SR
JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
[TBL] [Abstract][Full Text] [Related]
11. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
[TBL] [Abstract][Full Text] [Related]
12. Intracranial hypertension and memory loss in a patient treated with ustekinumab.
Abdelnabi M; Short J; Khoromi S; Ehrlich A
Australas J Dermatol; 2015 May; 56(2):146-7. PubMed ID: 25900637
[No Abstract] [Full Text] [Related]
13. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.
de Souza A; Ali-Shaw T; Reddy SM; Fiorentino D; Strober BE
Br J Dermatol; 2013 Jan; 168(1):210-2. PubMed ID: 23278559
[TBL] [Abstract][Full Text] [Related]
14. Positioning biologics-A case-based discussion: Ustekinumab.
Begun J
J Gastroenterol Hepatol; 2018 Sep; 33 Suppl 3():16-17. PubMed ID: 30187551
[No Abstract] [Full Text] [Related]
15. Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
Venegas-Iribarren S; Andino-Navarrete R
Medwave; 2018 Mar; 18(2):e7174. PubMed ID: 29522505
[TBL] [Abstract][Full Text] [Related]
16.
Borrás-Blasco J; Cortes X; Fernandez-Martinez S; Casterá E; Antequera B
Am J Health Syst Pharm; 2017 Feb; 74(4):209-212. PubMed ID: 28179246
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice].
Michel M; Reguiai Z; Fauconier M; Brochot P; Eschard JP; Salmon JH
Therapie; 2016 Jun; 71(3):281-6. PubMed ID: 27235651
[TBL] [Abstract][Full Text] [Related]
18. Ustekinumab Improves Paradoxical Enteropathy Associated With Psoriasis Arthritis.
Urushikubo J; Kawasaki K; Eizuka M; Yanai S; Nakamura S; Sugai T; Matsumoto T
Inflamm Bowel Dis; 2019 Sep; 25(10):e128-e129. PubMed ID: 31300828
[No Abstract] [Full Text] [Related]
19. Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.
Ghosh S; Gensler LS; Yang Z; Gasink C; Chakravarty SD; Farahi K; Ramachandran P; Ott E; Strober BE
Drug Saf; 2019 Jun; 42(6):751-768. PubMed ID: 30739254
[TBL] [Abstract][Full Text] [Related]
20. The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis.
Zabotti A; Goletti D; Lubrano E; Cantini F
Expert Opin Drug Saf; 2020 Jan; 19(1):69-82. PubMed ID: 31847608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
